title: Symptomatic conduction system disease in cardiac amyloidosis.
abstract: Symptomatic conduction system disease in cardiac amyloidosis and its management has been reported infrequently. We report our experience of patients with amyloidosis having symptomatic conduction system disease requiring permanent pacemaker implantation.
authors.affiliation: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
authors.forename: V
authors.initials: V
authors.lastname: Mathew
authors.forename: L J
authors.initials: LJ
authors.lastname: Olson
authors.forename: M A
authors.initials: MA
authors.lastname: Gertz
authors.forename: D L
authors.initials: DL
authors.lastname: Hayes
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000150:complications* / Q000401:mortality / Q000628:therapy; D001145:Arrhythmias, Cardiac / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D002304:Cardiac Pacing, Artificial / Q000009:adverse effects / Q000379:methods; D009202:Cardiomyopathies / Q000150:complications* / Q000401:mortality / Q000628:therapy; D017147:Defibrillators, Implantable / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000503:physiopathology*; D006801:Humans; D008297:Male; D015996:Survival Rate; D016896:Treatment Outcome